The Alliance’s blog offers a personal, inside look at our activities and perspectives on a range of timely issues. We encourage your feedback.


Author: Noel Lloyd

Date: September 9th, 2015

On August 27, the Aging in Motion (AIM) Coalition presented an one-hour webinar titled "Stakeholder Perspectives on Sarcopenia Patient-Reported Outcome Measures." It featured experts Ronenn Roubenoff, M.D., MHS, Novartis Institutes for Biomedical Research, Stephen Joel Coons, Ph.D., The Critical Path Institute, and Wen-Hung Chen, Ph.D., U.S. Food and Drug Administration, and it was moderated by AIM Executive Director Cynthia Bens. The webinar explored diverse stakeholder perspectives on the role of PRO measures in supporting the regulatory assessment of sarcopenia treatments and featured the relevance of PRO measures in capturing changes in mobility and improvements in quality of life for sarcopenic patients.  We are pleased to make this webinar available for viewing on demand. To watch it, please click on the graphic below.

A Tribute to a Great Scientist

Author: Dan Perry

Date: March 11th, 2008

FDA Needs More Funding to Fulfill Its Mission

Author: Cynthia Bens

Date: March 18th, 2008

Spending or Investing? -- The Silver Book & Innovation

Author: Lindsay Clarke

Date: March 26th, 2008

Preventing the Flu: A Q & A with Dr. William Schaffner

Author: Noel Lloyd

Date: December 4th, 2017

A Recap of the Clinical Trials for Alzheimer’s Disease Conference

Author: Phyllis Greenberger

Date: December 1st, 2017

An Update on the Clinical Trials for Alzheimer’s Disease Conference

Author: Noel Lloyd

Date: November 7th, 2017

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It